0001415889-23-006750.txt : 20230420
0001415889-23-006750.hdr.sgml : 20230420
20230420160547
ACCESSION NUMBER: 0001415889-23-006750
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230418
FILED AS OF DATE: 20230420
DATE AS OF CHANGE: 20230420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klein Matthew B.
CENTRAL INDEX KEY: 0001808968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 23833143
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
form4-04202023_080437.xml
X0407
4
2023-04-18
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001808968
Klein Matthew B.
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
false
true
false
false
CHIEF EXECUTIVE OFFICER
1
Common Stock
2023-04-18
4
A
0
26000
0
A
103856
D
Common Stock
2023-04-18
4
S
0
1211
52.0437
D
102645
D
Stock Option (Right to Buy)
52.96
2023-04-18
4
A
0
65000
0
A
2033-04-17
Common Stock
65000
65000
D
Restricted stock units granted on April 18, 2023 that vest in four equal installments over four years, commencing on April 18, 2024.
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from an April 16, 2020 grant of 10,000 RSUs.
This option was granted on April 18, 2023, and vests over four years, with 25% of the shares underlying the option vesting on April 18, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on July 18, 2024.
/s/ Avraham S. Adler, Attorney-in-Fact
2023-04-20